CBG (Cannibigerol) is sometimes referred to as the 'Mother of all Cannabinoids' as it is the precursor to other major cannabinoids, including CBD, CBC and THC. CBG showed promise for treating MRSA as an anti-bacterial. CBG has potential to treat bacteria that are resistant to traditional antibiotics.
If scientists can confirm the anti-inflammatory properties of CBG, it may have broad applications far beyond the treatment of colitis. Chronic inflammation is most often associated with painful conditions such as arthritis. However, it is also linked to many serious disorders, including high blood pressure, heart disease, diabetes, depression, and cancer.
It is, therefore, highly desirable to find new ways of reducing inflammation to prevent and treat these potentially fatal conditions. Although more research is required, cannabinoids, including CBG, could offer one such hope.
The Neuroprotective Effects of CBG
Aside from anti-inflammatory effects, CBG may also act as an antioxidant and protect the nervous system from damage. It does this in a similar way to the endocannabinoid 2-AG.
Another animal study on the neuroprotective effects of CBG produced some interesting results. It found that CBG could help to improve motor deficits and preserve neurons in neurodegenerative diseases, such as Huntington’s disease.
The Antimicrobial Effects of CBG
CBG, along with some other cannabinoids, has demonstrated antibacterial effects. When researchers tested it against various strains of Staphylococcus aureus bacterium in a laboratory, CBG was found to have significant antimicrobial properties. This finding could be especially crucial in the future, as antibiotic resistance is now becoming more and more commonplace.